Skip to main content

ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei

This is a preview of subscription content, access via your institution.


  1. Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14–26.

    Article  PubMed  Google Scholar 

  2. Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M. Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei in a single-center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:404–13.

    Article  PubMed  Google Scholar 

  3. Pietrantonio F, Perrone F, Mennitto A, et al. Toward the molecular dissection of peritoneal pseudomyxoma. Ann Oncol. 2016;27:2097–103.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Dario Baratti MD.

Ethics declarations


There are no conflicts of interest.

Additional information

ASO Author Reflections offer a brief invited commentary on the article, "Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy", Ann Surg Oncol. 2018;25:404–13.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Baratti, D. ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei. Ann Surg Oncol 25, 844–845 (2018).

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI:


  • Pseudomyxoma Peritonei (PMP)
  • Pathological Classification
  • Peritoneal Surface Oncology Group International (PSOGI)
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Cytoreductive Surgery